Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 2.98% |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | -6.08% |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 5.46% |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 10.06% |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | -4.66% |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 32.94% |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -13.59% |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 10.74% |
| 10 | Insight Molecular Diagnostics | 4.29 Mn | -24.64 Mn | 15,000.00 | -9.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.66% |
| Dec 31, 2025 | -34.95% |
| Sep 30, 2025 | -45.29% |
| Jun 30, 2025 | -39.11% |
| Mar 31, 2025 | -38.26% |
| Dec 31, 2024 | -33.61% |
| Sep 30, 2024 | -37.58% |
| Jun 30, 2024 | -42.17% |
| Mar 31, 2024 | -31.31% |
| Dec 31, 2023 | -21.09% |
| Sep 30, 2023 | -30.15% |
| Jun 30, 2023 | -15.06% |
| Mar 31, 2023 | -3.81% |
| Sep 30, 2022 | 57.06% |
| Jun 30, 2022 | 47.12% |
| Mar 31, 2022 | 43.09% |
| Dec 31, 2021 | 62.14% |
| Sep 30, 2021 | 75.20% |
| Jun 30, 2021 | 72.48% |
| Mar 31, 2021 | 54.91% |